Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172693 | SCV000055056 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000154985 | SCV000204667 | likely benign | not specified | 2015-04-24 | criteria provided, single submitter | clinical testing | p.Ile5633Thr in exon 68 of TTN: This variant is not expected to have clinical si gnificance because it has been identified in 0.4% (37/9774) of African chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs142794598). |
Eurofins Ntd Llc |
RCV000154985 | SCV000231970 | likely benign | not specified | 2017-01-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000172693 | SCV000238284 | likely benign | not provided | 2021-06-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23861362) |
Labcorp Genetics |
RCV001081624 | SCV000555280 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000172693 | SCV000616019 | likely benign | not provided | 2018-03-23 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000172693 | SCV001473651 | likely benign | not provided | 2024-05-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154985 | SCV002555937 | likely benign | not specified | 2025-04-04 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.16898T>C (p.Ile5633Thr) results in a non-conservative amino acid change located in the I-band of the encoded protein sequence. Two of three in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00027 in 247418 control chromosomes, predominantly at a frequency of 0.0038 within the African or African-American subpopulation in the gnomAD database, including 1 homozygote. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 10-fold of the estimated maximal expected allele frequency for a pathogenic variant in TTN causing Dilated Cardiomyopathy phenotype (0.00039). To our knowledge, no occurrence of c.16898T>C in individuals affected with Dilated Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 178246). Based on the evidence outlined above, the variant was classified as likely benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV003486695 | SCV004239845 | benign | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004534980 | SCV004740629 | likely benign | TTN-related disorder | 2022-03-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |